Does a life sciences company need a fractional CRO or a full-time CRO in 2027?

Direct Answer

Life sciences companies—biotech, medtech, diagnostics, and pharma services—face long sales cycles, heavy regulatory requirements, and multi-stakeholder buying processes. In 2027, the question isn't "fractional or full-time?" but rather "what does my company need right now?" A fractional CRO works well when you have a clear revenue playbook that needs execution, limited cash for a full-time hire, or a specific project like launching a new product or entering a new market. A full-time CRO is better when you need a permanent leader to build culture, manage a growing team, and own long-term strategy. Be honest: many founders hire a full-time CRO too early, burning equity and cash on someone who spends half their time on non-revenue tasks. A fractional CRO can avoid that trap.

When a fractional CRO makes sense in life sciences

Life sciences companies face unique revenue challenges that make fractional leadership attractive. Sales cycles often stretch 6 to 18 months due to clinical validation, regulatory approvals, and procurement processes. A fractional CRO can step in to build a repeatable sales process, train reps on complex stakeholder mapping, and implement tools like Salesforce or HubSpot without the overhead of a full-time executive. If your company is pre-revenue or under $2M ARR, a fractional CRO is almost always the better choice—you get experienced leadership without the equity dilution or salary commitment.

Example scenario: A diagnostics startup with $1.5M ARR needs to enter the hospital system market. The founder is the primary seller. A fractional CRO can design a territory plan, coach the founder on enterprise sales, and negotiate key contracts over 6 months. After that, the company may hire a full-time VP of Sales or CRO.

When a full-time CRO is necessary

A full-time CRO becomes essential when your company has $5M+ ARR, a growing sales team of 5+ reps, and complex channel partnerships. In life sciences, this often means managing key opinion leader (KOL) relationships, clinical trial site contracts, or distributor networks. A full-time executive can build sales compensation plans, hire and fire, and own the revenue forecast for the board. If you have more than 24 months of runway and a clear path to $20M+ ARR, a full-time CRO is a justified investment.

Warning: Don't hire a full-time CRO just because you think you "should." Many life sciences CEOs hire too early, then spend 6 months unwinding a bad fit. A fractional CRO can test the role before making a permanent commitment.

How to evaluate fractional CRO candidates in life sciences

Not all fractional CROs understand life sciences. Look for specific domain experience—medtech, biotech, diagnostics, or pharma services. Ask about their experience with FDA regulatory pathways, clinical trial sales, or hospital system procurement. A strong candidate should name real tools they've used: Salesforce for CRM, Gong for call coaching, Clari for forecasting, Outreach or Salesloft for sequencing. They should also reference communities like Pavilion or RevOps Co-op for ongoing learning.

Practical test: Ask them to describe how they'd build a sales process for a novel diagnostic test targeting hospital labs. The answer should include stakeholder mapping (lab director, CFO, CMO), regulatory considerations (CLIA, FDA), and reimbursement strategy (CPT codes, payer coverage). If they can't articulate this, keep looking.

Cost comparison: fractional vs. full-time in 2027

Fractional CRO costs range from $8,000 to $20,000 per month for 8–12 days of work. The range depends on the CRO's experience, the company's stage, and the scope of work. Early-stage companies typically pay $8,000–$12,000/month for 8 days. Later-stage or complex engagements (e.g., launching a new product line) can cost $15,000–$20,000/month for 12 days. Equity is sometimes included but not standard.

Full-time CRO costs range from $250,000 to $400,000+ total annual comp. This includes base salary ($180,000–$250,000), bonus (20–40% of base), and equity (0.5–2% of company). In life sciences, expect the high end due to specialized domain knowledge. Add recruiting fees (20–30% of first-year cash comp) if using a search firm.

Hidden costs of full-time: Benefits, payroll taxes, travel expenses, and the cost of a bad hire (3–6 months of lost time and pipeline). Fractional CROs carry no such overhead.

The decision framework: a mermaid flowchart

How to structure a fractional CRO engagement

A successful fractional CRO engagement in life sciences requires clear scope, measurable outcomes, and regular check-ins. Start with a 90-day contract that defines specific deliverables: a sales process document, a pipeline review cadence, coaching sessions for reps, and key account plans for top opportunities. The fractional CRO should work 8–12 days per month, with at least 2 days on-site (if local) or virtual for team meetings.

Metrics to track: Pipeline coverage ratio (e.g., 3x quota), win rate by segment, average deal size, and sales cycle length. The fractional CRO should report weekly to the CEO and monthly to the board. After 90 days, evaluate whether to extend, convert to full-time, or end the engagement.

The revenue leadership maturity model

This model shows the typical progression. Most life sciences companies start with founder-led sales (the CEO or CSO sells). A fractional CRO then builds the sales process, trains the team, and creates repeatability. Once ARR reaches $5M–$10M, a full-time CRO takes over to scale the team. Eventually, the company may add a VP of Sales and a RevOps function. The key is not to skip steps—hiring a full-time CRO too early wastes resources.

FAQ

What specific life sciences experience should a fractional CRO have? Look for experience in medtech, biotech, diagnostics, or pharma services. They should understand FDA regulatory pathways, clinical trial sales, hospital system procurement, and reimbursement strategy. Ask for examples of complex deals they've closed in your sub-sector.

Can a fractional CRO work remotely for a life sciences company? Yes, most fractional CROs work remote or hybrid. They should be willing to travel 2–4 days per month for key meetings, customer visits, or team events. In smaller markets, remote fractional CROs are the norm.

How long does a typical fractional CRO engagement last? Most engagements are 3–12 months. Some extend to 18 months if the company is scaling quickly. The contract should be month-to-month or quarterly to allow flexibility.

What if I hire a fractional CRO and they don't work out? That's the advantage—low risk. You can end the engagement with 30 days' notice (or per contract terms). A bad full-time hire costs 6–12 months of salary plus severance. A bad fractional hire costs 1–3 months of fees.

How do I find a good fractional CRO for life sciences?

Should I offer equity to a fractional CRO? Equity is not standard for fractional CROs, but it can be offered for longer engagements (12+ months) or high-impact roles (e.g., leading a fundraising round). Typical equity is 0.1–0.5% with a 1-year cliff and 3-year vesting. Most fractional CROs prefer cash.

Sources

• Pavilion – community for revenue leaders
• RevOps Co-op – operations best practices
• Harvard Business Review – sales leadership and organizational design
• First Round Review – startup leadership and hiring
• SaaStr – SaaS and subscription business insights
• LinkedIn – professional network for vetting candidates

People also search for: fractional cro · hire a fractional cro · fractional cro near me · fractional cro cost